Aromatase inhibitors for treatment of estrogen-sensitive breast tumors
Record ID 32005000014
English
Authors' objectives:
Aromatase inhibitors (AIs) prevent the enzyme aromatase from converting other naturally occurring hormones into estrogen, thereby limiting the amount of estrogen available for breast cancer tumor growth. AIs are used after failure of tamoxifen to prevent breast cancer recurrence, as a first-line therapy in women with early breast cancer, and as an adjuvant treatment for women with advanced breast cancer.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=2203
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Aromatase
- Enzyme Inhibitors
- Breast Neoplasms
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.